Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Fonteneau

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Discovery|March 18, 2025
Cytosolic Phospholipase A2 determines Intercellular Heterogeneity of Stress Granules and Chemotherapy ResponseAlexandra Redding, Guillaume Fonteneau, Stefan Heinrich, et al.
Cancer Discovery|June 8, 2022
Stress Granules Determine the Development of Obesity-Associated Pancreatic CancerGuillaume Fonteneau, Alexandra Redding, Hannah Hoag-Lee, et al.
Cell & Bioscience|October 19, 2021
Neuromedin B promotes chondrocyte differentiation of mesenchymal stromal cells via calcineurin and calcium signalingMarie Maumus, Guillaume Fonteneau, Maxime Ruiz, et al.
Journal of Autoimmunity|April 8, 2016
Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosisAlexandre T J Maria, Karine Toupet, Marie Maumus, et al.
Frontiers in Immunology|September 19, 2017
Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell FunctionGuillaume Fonteneau, Claire Bony, Radjiv Goulabchand, et al.
Frontiers in Immunology|January 10, 2019
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic SclerosisAlexandre T J Maria, Pauline Rozier, Guillaume Fonteneau, et al.
Molecular Cancer Therapeutics|March 18, 2016
Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary TumorsMarie Chanal, Pascale Chevallier, Véronique Raverot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Discovery|March 18, 2025
Cytosolic Phospholipase A2 determines Intercellular Heterogeneity of Stress Granules and Chemotherapy ResponseAlexandra Redding, Guillaume Fonteneau, Stefan Heinrich, et al.
Cancer Discovery|June 8, 2022
Stress Granules Determine the Development of Obesity-Associated Pancreatic CancerGuillaume Fonteneau, Alexandra Redding, Hannah Hoag-Lee, et al.
Cell & Bioscience|October 19, 2021
Neuromedin B promotes chondrocyte differentiation of mesenchymal stromal cells via calcineurin and calcium signalingMarie Maumus, Guillaume Fonteneau, Maxime Ruiz, et al.
Journal of Autoimmunity|April 8, 2016
Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosisAlexandre T J Maria, Karine Toupet, Marie Maumus, et al.
Frontiers in Immunology|September 19, 2017
Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell FunctionGuillaume Fonteneau, Claire Bony, Radjiv Goulabchand, et al.
Frontiers in Immunology|January 10, 2019
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic SclerosisAlexandre T J Maria, Pauline Rozier, Guillaume Fonteneau, et al.
Molecular Cancer Therapeutics|March 18, 2016
Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary TumorsMarie Chanal, Pascale Chevallier, Véronique Raverot, et al.
Pageof 1